The out-of-pocket cost cap of $£35 at participating ... and less than $8 in the UK. Eli Lilly together with Sanofi and Novo Nordisk make up 90% of the US market for insulin.

Eli Lilly and Company's Q4 and ... pipeline and strong financial performance, Lilly is poised to potentially become the first trillion-dollar market cap pharma company by 2025.

Eli Lilly and Company (NYSE:LLY – Get Free Report) traded up 0.1% during mid-day trading on Monday after Truist Financial raised their price target on the stock from $1,029.00 to $1,038.00. Truist ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Arkansas has become the latest US state to issue a legal challenge to the big three insulin producers – Eli Lilly ... voted to introduce a $35 cap on the monthly cost of insulin to patients ...

The S&P 500 and the Nasdaq ended higher while the Dow closed lower after a choppy trading session on Thursday, as investors sifted through earnings reports and awaited Amazon's results after the ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.